Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome
Manuela Colucci, Andrea Angeletti, Federica Zotta, et al.
Kidney International (2023) Vol. 104, Iss. 3, pp. 577-586
Closed Access | Times Cited: 10

Showing 10 citing articles:

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
Şafak Mirioğlu, Lisa Daniel-Fischer, İlay Berke, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 4, pp. 569-580
Open Access | Times Cited: 15
Risk factors and retreatment for relapse in childhood primary nephrotic syndrome treated with rituximab
Yuanzhao Zhi, Lu Cao, Rui Gu, et al.
Pediatric Nephrology (2025)
Closed Access | Times Cited: 1
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients
Martina Riganati, Ester Conversano, Federica Zotta, et al.
Pediatric Nephrology (2025)
Closed Access
Anti-CD20 monoclonal antibodies for idiopathic nephrotic syndrome: Advances, challenges, and future directions
Andrea Angeletti, Gian Marco Ghiggeri
Pediatric Nephrology (2025)
Open Access
The efficacy and dynamic changes of immune function of rituximab with mycophenolate mofetil in the treatment of steroid-dependent /frequently relapsing nephrotic syndrome: a retrospective follow-up study
Songlei Gu, Tong Shen, Yi­hui Zhai, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Identification of Risk Factors for Relapse Following Rituximab Therapy in Children with Steroid-Sensitive Nephrotic Syndrome
Ling Chen, Zhi Chen, Yue Xi, et al.
(2025)
Closed Access
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Eugene Yu-hin Chan, Olivia Boyer
Pediatric Nephrology (2024)
Open Access | Times Cited: 1
Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult
Qiang Wang, Lin Lin, Junhui Zhen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?
Francesco Locatelli, Ernesto Paoletti, Maura Ravera, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1145-1161
Closed Access
The pathogenesis of nephrotic syndrome: a perspective from B-cells
Shifan Zhu, Jiayu Zhang, Langping Gao, et al.
Kidney Diseases (2024), pp. 1-14
Open Access
Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials
Jessica Felicia Ang, Nicolas Daniel Widjanarko, Anthony Ekaputra
Tzu Chi Medical Journal (2024) Vol. 36, Iss. 3, pp. 319-329
Open Access
Page 1

Scroll to top